Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/26/24 21:00 | 12/20/24 | FATE | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | P.d | 669 | 1.68 | 0 | 398 | 3 | 12,884 | I | |||||||||||||||
12/28/23 21:30 | 12/26/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | P | 166 | 3.72 | 0 | 45 | 0 | 13,180 | I | |||||||||||||||
4/21/23 21:55 | 4/20/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | P.m | 1,706 | 6.17 | 0 | 277 | 2 | 13,136 | I | |||||||||||||||
4/17/23 21:30 | 4/14/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Redmile Group, LLC | CA | DT | P.d | 154 | 6.00 | 0 | 26 | 0 | 12,859 | I | |||||||||||||||
1/13/23 18:20 | 1/11/23 | FATE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | P.m | 698 | 5.60 | 0 | 125 | 79 | 283 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |